Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BiDil XR vs BiDil IR PK/PD in Black Heart Failure Patients
NCT02522208Phase 1Completed
- Start
- Sep 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of isosorbide dinitrate in heart failure (HF) (2 arms). Primary endpoint: Pulmonary Artery Systolic Pressure change from baseline at 28 hours. Started Sep 2015; status: completed.
02
Drugs
isosorbide dinitrate
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02522208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02522208.